Celik Yamaci, M.; Pamukcu, C.; Erdemgil, Y.; Atik, A.E.; Keles, Z.Z.Y.; Can, O.
Comparative Forced Degradation Study of Anticomplement C5 Biosimilar and Originator Monoclonal Antibodies. Pharmaceuticals 2025, 18, 579.
https://doi.org/10.3390/ph18040579
AMA Style
Celik Yamaci M, Pamukcu C, Erdemgil Y, Atik AE, Keles ZZY, Can O.
Comparative Forced Degradation Study of Anticomplement C5 Biosimilar and Originator Monoclonal Antibodies. Pharmaceuticals. 2025; 18(4):579.
https://doi.org/10.3390/ph18040579
Chicago/Turabian Style
Celik Yamaci, Merve, Ceren Pamukcu, Yigit Erdemgil, Ahmet Emin Atik, Zeynep Zulfiye Yildirim Keles, and Ozge Can.
2025. "Comparative Forced Degradation Study of Anticomplement C5 Biosimilar and Originator Monoclonal Antibodies" Pharmaceuticals 18, no. 4: 579.
https://doi.org/10.3390/ph18040579
APA Style
Celik Yamaci, M., Pamukcu, C., Erdemgil, Y., Atik, A. E., Keles, Z. Z. Y., & Can, O.
(2025). Comparative Forced Degradation Study of Anticomplement C5 Biosimilar and Originator Monoclonal Antibodies. Pharmaceuticals, 18(4), 579.
https://doi.org/10.3390/ph18040579